Thyroid Disease and Chemical Exposure: Perchlorate, PFAS, and Flame Retardants

The thyroid gland has a particular relationship with halogens — the chemical family that includes fluorine, chlorine, bromine, and iodine. Its entire function depends on iodine: the gland actively concentrates iodide from the bloodstream to synthesise thyroid hormones T3 and T4, which regulate metabolism, temperature, growth, and virtually every organ system in the body.

This biochemical dependence on a specific halogen creates a vulnerability. Other halogens — perchlorates, thiocyanates, nitrates — compete with iodide for uptake by the thyroid's sodium-iodide symporter, the transport protein that concentrates iodine in the gland. Organic halogenated compounds — PFAS, PCBs, flame retardants — interfere with thyroid hormone synthesis, transport, and receptor binding at the molecular level.

The thyroid gland is, in short, designed to be exceptionally responsive to iodine and structurally vulnerable to chemicals that resemble or interfere with it. In a world that has distributed these chemicals broadly through water, food, and consumer products, thyroid disease has correspondingly expanded: hypothyroidism, Hashimoto's thyroiditis, thyroid nodules, and thyroid cancer are all rising in prevalence in ways that basic demographic and iodine-status changes alone cannot fully explain.

Perchlorate — a chemical used in rocket propellant, explosives, fireworks, and some fertilisers — is a potent competitive inhibitor of the thyroid's sodium-iodide symporter. At sufficient concentrations, it blocks iodine uptake by the thyroid far more effectively than iodine itself competes.

It is also ubiquitous in US drinking water.

The contamination landscape Perchlorate contaminates groundwater near military installations, aerospace facilities, and agricultural areas where perchlorate-containing fertilisers were historically used. A 2009 CDC analysis of NHANES data detected perchlorate in the urine of all 2,820 participants tested — every single person. The geometric mean was 3.4 µg/L — well within the range at which thyroid effects are biologically plausible, particularly in iodine-deficient individuals.

Who is most vulnerable Perchlorate's thyroid effects are most significant in populations with marginal iodine status — who cannot compensate for reduced iodide uptake by drawing on body reserves. Pregnant women (whose iodine requirements are elevated), people with pre-existing thyroid disease, and infants fed formula made with perchlorate-containing water are most at risk.

The regulatory gap The EPA proposed a perchlorate MCL of 56 µg/L in 2019 — later modified — but as of this writing, no enforceable federal MCL exists. Several states have set their own standards, but the majority of Americans drink water without any perchlorate regulation. The absence of an MCL means utilities are not required to test for or report perchlorate levels.

PFAS and polybrominated diphenyl ethers (flame retardants) represent two distinct mechanisms of thyroid hormone disruption that compound each other in a population simultaneously exposed to both.

PFAS and thyroid disruption PFAS interfere with thyroid hormone transport by binding to transthyretin — one of the primary carrier proteins that transports T4 through the bloodstream. By competing with T4 for transthyretin binding, PFAS effectively reduce free T4 availability. Multiple epidemiological studies have found associations between PFAS blood levels and altered thyroid hormone concentrations, with the most consistent finding being suppressed T4 levels in exposed populations.

The C8 Health Study and subsequent analyses in the Parkersburg, West Virginia population — one of the highest-exposed PFAS populations studied — found higher rates of thyroid disease and thyroid medication use in high-PFAS residents compared to comparable unexposed populations.

PBDEs and the structural mimicry problem PBDEs (polybrominated diphenyl ethers) are structurally very similar to thyroid hormones — both are halogenated diphenyl compounds. This structural mimicry allows PBDEs to bind thyroid hormone receptors and transport proteins, producing thyroid disruption through direct competition with T3 and T4 at their molecular targets. Studies of PBDE body burden in pregnant women have found associations between higher PBDE levels and lower maternal thyroid hormone levels — a concern during pregnancy when thyroid hormone is essential for foetal brain development.

For people with thyroid disease — or those concerned about thyroid health given their exposure history — the connection between environmental chemicals and thyroid function has specific clinical implications.

When to discuss environmental exposure with a thyroid specialist: • Unexplained hypothyroidism, particularly in younger adults without autoimmune markers • Thyroid nodules or goitre without clear iodine deficiency • Treatment-resistant hypothyroidism where standard levothyroxine doses don't achieve expected TSH normalisation • Elevated thyroid peroxidase antibodies (Hashimoto's) alongside known significant environmental chemical exposure

Relevant tests to discuss: • TSH, free T3, free T4 — the standard thyroid panel provides the baseline • Anti-TPO and anti-thyroglobulin antibodies — relevant if autoimmune thyroiditis is suspected • Urinary iodine — establishes iodine status, which determines susceptibility to perchlorate and other competitors • PFAS blood panel — now available through reference laboratories; clinically informative given PFAS's transthyretin binding effects

Iodine optimisation Ensuring adequate iodine intake — through iodised salt, seaweed, seafood, and dairy — maximises the thyroid's ability to compete with perchlorate and other iodine competitors. This is not iodine supplementation beyond normal dietary levels but ensuring that dietary iodine is not deficient, which would amplify susceptibility to competitive inhibitors.

PollutionProfile's Historical Exposure Recorder can document PFAS water exposure, proximity to facilities using perchlorates, and occupational chemical exposure relevant to thyroid health — providing the context for a more complete clinical conversation than standard thyroid assessment typically includes.